Restart Life Sciences Corp.
NMLSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $5 | $0 |
| G&A Expenses | $109 | $98 | $613 | $226 |
| SG&A Expenses | $109 | $98 | $613 | $226 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $62 | $65 | $67 | $59 |
| Operating Expenses | $171 | $163 | $685 | $285 |
| Operating Income | -$171 | -$163 | -$685 | -$285 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$40 | -$41 | -$134 | $285 |
| Pre-Tax Income | -$211 | -$203 | -$819 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$211 | -$203 | -$819 | $0 |
| % Margin | – | – | – | – |
| EPS | -0.01 | -0.006 | -30.63 | -0 |
| % Growth | -63.9% | 100% | -7,657,400% | – |
| EPS Diluted | -0.01 | -0.01 | -30.63 | -0.001 |
| Weighted Avg Shares Out | 35,887 | 33,590 | 27 | 15,286 |
| Weighted Avg Shares Out Dil | 35,887 | 33,590 | 27 | 16,114 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $1 |
| EBITDA | -$171 | -$162 | -$685 | -$298 |
| % Margin | – | – | – | – |